MolDX: Pharmacogenomics Testing (L38335) - R1 - Effective August 24, 2023

This Local Coverage Determination (LCD) has been revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Medicare Coverage Database (MCD) Number: L38335

LCD Title: MolDX: Pharmacogenomics Testing

Effective Date: August 24, 2023

Summary of Changes: Under CMS National Coverage Policy added the following regulations, "Title XVIII of the Social Security Act (SSA), §1862(a)(1)(A), 42 CFR §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions, and CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, §80.1.1 Certification Changes". Under Bibliography changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation and typographical errors were corrected throughout the LCD.

Visit the Molecular Diagnostic Services (MolDX) webpage to access the MolDX Medicare Local Coverage Determination from the "Active LCD" Webpage.

Visit the Active LCDs webpage to view the Active LCD or access it via the CMS MCD.

Last Updated Aug 25 , 2023